semaglutide gel Use of linked to doubled risk of neovascular macular degeneration weekly injection utilized for the management of type 2 diabetes mellitus Oral semaglutide drops - No
Description
People taking a GLP-1, they found, had a noticeably greater chance of being diagnosed with smell or taste problems than those taking a different diabetes drug
Its given as a subcutaneous injection, typically once a week
Originally developed for type 2 diabetes under the brand name Ozempic, semaglutide was later approved at a higher dose as Wegovy specifically for chronic weight management
2015;136(2):28894 e8
